Delivered-To: sometime5858@gmail.com
Received: by 10.60.21.38 with SMTP id s6csp9731oee;
        Wed, 2 Apr 2014 23:29:07 -0700 (PDT)
X-Received: by 10.224.151.130 with SMTP id c2mr5294911qaw.67.1396506546798;
        Wed, 02 Apr 2014 23:29:06 -0700 (PDT)
Return-Path: <N.Bakota@nucleusnetwork.com.au>
Received: from mail1.bemta8.messagelabs.com (mail1.bemta8.messagelabs.com. [216.82.243.199])
        by mx.google.com with ESMTP id z3si1756267qcl.8.2014.04.02.23.28.13
        for <multiple recipients>;
        Wed, 02 Apr 2014 23:29:06 -0700 (PDT)
Received-SPF: neutral (google.com: 216.82.243.199 is neither permitted nor denied by best guess record for domain of N.Bakota@nucleusnetwork.com.au) client-ip=216.82.243.199;
Authentication-Results: mx.google.com;
       spf=neutral (google.com: 216.82.243.199 is neither permitted nor denied by best guess record for domain of N.Bakota@nucleusnetwork.com.au) smtp.mail=N.Bakota@nucleusnetwork.com.au
Return-Path: <N.Bakota@nucleusnetwork.com.au>
Received: from [216.82.242.147:16817] by server-7.bemta-8.messagelabs.com id E0/97-01858-A7FFC335; Thu, 03 Apr 2014 06:28:10 +0000
X-Env-Sender: N.Bakota@nucleusnetwork.com.au
X-Msg-Ref: server-2.tower-95.messagelabs.com!1396505173!30640575!11
X-Originating-IP: [59.167.118.49]
X-StarScan-Received:
X-StarScan-Version: 6.11.1; banners=nucleusnetwork.com.au,-,-
X-VirusChecked: Checked
Received: (qmail 25830 invoked from network); 3 Apr 2014 06:28:08 -0000
Received: from mail.nucleusnetwork.com.au (HELO PRNEX2010.nucleus.local) (59.167.118.49)
  by server-2.tower-95.messagelabs.com with SMTP; 3 Apr 2014 06:28:08 -0000
Received: from PRNEX2010.nucleus.local ([::1]) by PRNEX2010.nucleus.local
 ([::1]) with mapi id 14.02.0318.004; Thu, 3 Apr 2014 17:16:25 +1100
From: Natalie Bakota <N.Bakota@nucleusnetwork.com.au>
Subject: It's back - NN001 - PLEASE READ
Thread-Topic: It's back - NN001 - PLEASE READ
Thread-Index: Ac9OISZta2GzfXQrSxW01oRInITefwA3NtPAAADN43AAACBz0AAACDyw
Date: Thu, 3 Apr 2014 06:16:24 +0000
Message-ID: <43607F02F7F979429DE2661B9FCBF6DF3C61DEF3@PRNEX2010.nucleus.local>
Accept-Language: en-AU, en-US
Content-Language: en-US
X-MS-Has-Attach: yes
X-MS-TNEF-Correlator:
x-originating-ip: [192.168.100.109]
Content-Type: multipart/related;
	boundary="_004_43607F02F7F979429DE2661B9FCBF6DF3C61DEF3PRNEX2010nucleu_";
	type="multipart/alternative"
MIME-Version: 1.0
X-TUID: ZANmBzLWJOKu

--_004_43607F02F7F979429DE2661B9FCBF6DF3C61DEF3PRNEX2010nucleu_
Content-Type: multipart/alternative;
	boundary="_000_43607F02F7F979429DE2661B9FCBF6DF3C61DEF3PRNEX2010nucleu_"

--_000_43607F02F7F979429DE2661B9FCBF6DF3C61DEF3PRNEX2010nucleu_
Content-Type: text/plain; charset="us-ascii"
Content-Transfer-Encoding: quoted-printable

Hello,

Thank you again for your interest in our clinical trials. Please see brief=
 outline of a new research project below.



We are inviting all healthy males aged 18-70 years and healthy females of =
non-child bearing potential aged 18-70 years to participate in a research =
project  called NN001 by providing a blood sample. Participants who provid=
e a blood sample will receive a reimbursement of $25.

Please also feel free to forward this email to any of your healthy friends=
 aged 18-70 years who satisfy the above criteria and who may also be inter=
ested.


NN001 -This research project aims to evaluate the metabolism status of abo=
ut 2000 healthy adult Caucasian volunteers. It has been found that certain=
 common gene mutations may affect the way that certain drugs are metabolis=
ed by the body. By analysing a single sample of a person's blood for the p=
resence of these common gene mutations, their metabolism status can be det=
ermined. This research will assist us in understanding the metabolism stat=
us as it applies to the wider adult population. Each participant's results=
 will be recorded in a secure password protected database which we may use=
 in the future to recruit participants with a specific metabolic status fo=
r future clinical trials. There is no obligation for volunteers who provid=
e a blood sample to participate in any further studies however you will be=
 notified about future studies for which you could potentially be eligible=
.


Please ensure you also read the hyperlinked Participant Information & Cons=
ent Form (PICF) which gives more detail about this research project. If, a=
fter reading the PICF you are interested in providing us with a blood samp=
le then please call us on 1800 243 733 or respond to this email and includ=
e your phone number. We will then call you back as soon as possible. Pleas=
e note however, that when we return your call it will be from our private =
line. Also, if you get our voicemail, it's just because we are busy answer=
ing other calls so please keep trying to get through to us.



Please click here<http://clinicalstudies.com.au/locker/data/public/b0ce691=
d0493a9a3e85d3e2b7e29a29b.php?lang=3Den> to view the PICF (Participant Inf=
ormation & Consent Form)

Our Location      Centre for Clinical Studies (AMREP Precinct Alfred Hospi=
tal) AMREP access map<http://clinicalstudies.com.au/wp-content/uploads/201=
4/02/AMREP-CCS-Access-MAP.pdf>
                                Level 5, 89 Commercial Road,
                                Melbourne, 3004.
                              Click here<https://maps.google.com.au/maps?q=
=3D89+commercial+road+melbourne+3004&ie=3DUTF-8&hq=3D&hnear=3D0x6ad6682290=
2afed9:0xca1cf794638a5956,85-89+Commercial+Rd,+Melbourne+VIC+3004&gl=3Dau&=
ei=3DrwD8UqTNL4GRkwX88YH4Aw&ved=3D0CCYQ8gEwAA> for the Google map.


Please note that if you have previously provided us with a blood sample th=
en you cannot participate in this sub-study again as we already have your =
genotype results. However, if you know of anyone who may be interested, we=
 would very much appreciate it if you pass on the information.


Participants Required:

*         Healthy Caucasian Males (aged 18-70 years)

*         Healthy Women who are not of child bearing potential eg post men=
opausal (aged 18-70 years)

*         Weight - greater 50 kgs

*         BMI: 18-30

*         No medical conditions

*         Do not smoke more than 3 cigarettes per day



Reimbursement: $25 cash


Please also visit our website at www.clinicalstudies.com.au<http://www.cli=
nicalstudies.com.au>


To view our Participant Information Brochure please click here<http://www.=
nucleusnetwork.com.au/Upload/Content/File/Email%20related/Volunteer%20Broc=
hure%20(2).pdf> and read more about our organisation and about clinical tr=
ials generally.


If you do not wish to receive any further emails from us then please reply=
 to this email with the word 'unsubscribe' in the subject box.




Thank you again for your interest.

Kind Regards


Natalie Bakota


[See full size image]<http://www.facebook.com/pages/Centre-for-Clinical-St=
udies/199371513417842> You can now follow us on Facebook

Natalie Bakota|Recruitment Officer| Centre for Clinical Studies |
Office: | Level 5 Burnet Institute | AMREP Precinct | 89 Commercial Road |=
 Victoria 3004 | Australia
Mail: | PO Box 6083, St Kilda Road Central, Melbourne, 8008, Victoria, Aus=
tralia
Telephone: | t: 1800 243 733 | t: 03 9076 8936 | f: 03 9076 8940
N.Bakota@nucleusnetwork.com.au<mailto:N.Bakota@nucleusnetwork.com.au>   ww=
w.clinicalstudies.com.au<http://www.clinicalstudies.com.au/>
Nucleus Network, Australia's Clinical Research Centre, operates in associa=
tion with Centre for Clinical Studies, Clinical Trials Consulting and its =
network partners





______________________________________________________________________
This email has been scanned by the Symantec Email Security.cloud service.
For more information please visit http://www.symanteccloud.com
______________________________________________________________________
--_000_43607F02F7F979429DE2661B9FCBF6DF3C61DEF3PRNEX2010nucleu_
Content-Type: text/html; charset="us-ascii"
Content-Transfer-Encoding: quoted-printable

<html xmlns:v=3D"urn:schemas-microsoft-com:vml" xmlns:o=3D"urn:schemas-mic=
rosoft-com:office:office" xmlns:w=3D"urn:schemas-microsoft-com:office:word=
" xmlns:x=3D"urn:schemas-microsoft-com:office:excel" xmlns:p=3D"urn:schema=
s-microsoft-com:office:powerpoint" xmlns:a=3D"urn:schemas-microsoft-com:of=
fice:access" xmlns:dt=3D"uuid:C2F41010-65B3-11d1-A29F-00AA00C14882" xmlns:=
s=3D"uuid:BDC6E3F0-6DA3-11d1-A2A3-00AA00C14882" xmlns:rs=3D"urn:schemas-mi=
crosoft-com:rowset" xmlns:z=3D"#RowsetSchema" xmlns:b=3D"urn:schemas-micro=
soft-com:office:publisher" xmlns:ss=3D"urn:schemas-microsoft-com:office:sp=
readsheet" xmlns:c=3D"urn:schemas-microsoft-com:office:component:spreadshe=
et" xmlns:odc=3D"urn:schemas-microsoft-com:office:odc" xmlns:oa=3D"urn:sch=
emas-microsoft-com:office:activation" xmlns:html=3D"http://www.w3.org/TR/R=
EC-html40" xmlns:q=3D"http://schemas.xmlsoap.org/soap/envelope/" xmlns:rtc=
=3D"http://microsoft.com/officenet/conferencing" xmlns:D=3D"DAV:" xmlns:Re=
pl=3D"http://schemas.microsoft.com/repl/" xmlns:mt=3D"http://schemas.micro=
soft.com/sharepoint/soap/meetings/" xmlns:x2=3D"http://schemas.microsoft.c=
om/office/excel/2003/xml" xmlns:ppda=3D"http://www.passport.com/NameSpace.=
xsd" xmlns:ois=3D"http://schemas.microsoft.com/sharepoint/soap/ois/" xmlns=
:dir=3D"http://schemas.microsoft.com/sharepoint/soap/directory/" xmlns:ds=3D=
"http://www.w3.org/2000/09/xmldsig#" xmlns:dsp=3D"http://schemas.microsoft=
.com/sharepoint/dsp" xmlns:udc=3D"http://schemas.microsoft.com/data/udc" x=
mlns:xsd=3D"http://www.w3.org/2001/XMLSchema" xmlns:sub=3D"http://schemas.=
microsoft.com/sharepoint/soap/2002/1/alerts/" xmlns:ec=3D"http://www.w3.or=
g/2001/04/xmlenc#" xmlns:sp=3D"http://schemas.microsoft.com/sharepoint/" x=
mlns:sps=3D"http://schemas.microsoft.com/sharepoint/soap/" xmlns:xsi=3D"ht=
tp://www.w3.org/2001/XMLSchema-instance" xmlns:udcs=3D"http://schemas.micr=
osoft.com/data/udc/soap" xmlns:udcxf=3D"http://schemas.microsoft.com/data/=
udc/xmlfile" xmlns:udcp2p=3D"http://schemas.microsoft.com/data/udc/parttop=
art" xmlns:wf=3D"http://schemas.microsoft.com/sharepoint/soap/workflow/" x=
mlns:dsss=3D"http://schemas.microsoft.com/office/2006/digsig-setup" xmlns:=
dssi=3D"http://schemas.microsoft.com/office/2006/digsig" xmlns:mdssi=3D"ht=
tp://schemas.openxmlformats.org/package/2006/digital-signature" xmlns:mver=
=3D"http://schemas.openxmlformats.org/markup-compatibility/2006" xmlns:m=3D=
"http://schemas.microsoft.com/office/2004/12/omml" xmlns:mrels=3D"http://s=
chemas.openxmlformats.org/package/2006/relationships" xmlns:spwp=3D"http:/=
/microsoft.com/sharepoint/webpartpages" xmlns:ex12t=3D"http://schemas.micr=
osoft.com/exchange/services/2006/types" xmlns:ex12m=3D"http://schemas.micr=
osoft.com/exchange/services/2006/messages" xmlns:pptsl=3D"http://schemas.m=
icrosoft.com/sharepoint/soap/SlideLibrary/" xmlns:spsl=3D"http://microsoft=
.com/webservices/SharePointPortalServer/PublishedLinksService" xmlns:Z=3D"=
urn:schemas-microsoft-com:" xmlns:st=3D"&#1;" xmlns=3D"http://www.w3.org/T=
R/REC-html40">
<head>
<meta http-equiv=3D"Content-Type" content=3D"text/html; charset=3Dus-ascii=
">
<meta name=3D"Generator" content=3D"Microsoft Word 12 (filtered medium)">
<!--[if !mso]><style>v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style><![endif]--><style><!--
/* Font Definitions */
@font-face
=09{font-family:"Cambria Math";
=09panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
=09{font-family:Calibri;
=09panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
=09{font-family:Tahoma;
=09panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
=09{font-family:Consolas;
=09panose-1:2 11 6 9 2 2 4 3 2 4;}
@font-face
=09{font-family:"Edwardian Script ITC";
=09panose-1:3 3 3 2 4 7 7 13 8 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
=09{margin:0cm;
=09margin-bottom:.0001pt;
=09font-size:11.0pt;
=09font-family:"Calibri","sans-serif";}
a:link, span.MsoHyperlink
=09{mso-style-priority:99;
=09color:blue;
=09text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
=09{mso-style-priority:99;
=09color:purple;
=09text-decoration:underline;}
p.MsoPlainText, li.MsoPlainText, div.MsoPlainText
=09{mso-style-priority:99;
=09mso-style-link:"Plain Text Char";
=09margin:0cm;
=09margin-bottom:.0001pt;
=09font-size:10.5pt;
=09font-family:Consolas;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
=09{mso-style-priority:99;
=09mso-style-link:"Balloon Text Char";
=09margin:0cm;
=09margin-bottom:.0001pt;
=09font-size:8.0pt;
=09font-family:"Tahoma","sans-serif";}
span.PlainTextChar
=09{mso-style-name:"Plain Text Char";
=09mso-style-priority:99;
=09mso-style-link:"Plain Text";
=09font-family:Consolas;}
span.BalloonTextChar
=09{mso-style-name:"Balloon Text Char";
=09mso-style-priority:99;
=09mso-style-link:"Balloon Text";
=09font-family:"Tahoma","sans-serif";}
span.EmailStyle21
=09{mso-style-type:personal;
=09font-family:"Calibri","sans-serif";
=09color:windowtext;}
span.EmailStyle22
=09{mso-style-type:personal;
=09font-family:"Calibri","sans-serif";
=09color:#1F497D;}
span.EmailStyle23
=09{mso-style-type:personal;
=09font-family:"Calibri","sans-serif";
=09color:#1F497D;}
span.EmailStyle24
=09{mso-style-type:personal;
=09font-family:"Calibri","sans-serif";
=09color:#1F497D;}
span.EmailStyle25
=09{mso-style-type:personal-reply;
=09font-family:"Calibri","sans-serif";
=09color:#1F497D;}
.MsoChpDefault
=09{mso-style-type:export-only;
=09font-size:10.0pt;}
@page WordSection1
=09{size:612.0pt 792.0pt;
=09margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
=09{page:WordSection1;}
/* List Definitions */
@list l0
=09{mso-list-id:11108230;
=09mso-list-type:hybrid;
=09mso-list-template-ids:1383915062 201916417 201916419 201916421 20191641=
7 201916419 201916421 201916417 201916419 201916421;}
@list l0:level1
=09{mso-level-number-format:bullet;
=09mso-level-text:\F0B7;
=09mso-level-tab-stop:none;
=09mso-level-number-position:left;
=09text-indent:-18.0pt;
=09font-family:Symbol;}
@list l0:level2
=09{mso-level-tab-stop:72.0pt;
=09mso-level-number-position:left;
=09text-indent:-18.0pt;}
@list l0:level3
=09{mso-level-tab-stop:108.0pt;
=09mso-level-number-position:left;
=09text-indent:-18.0pt;}
@list l0:level4
=09{mso-level-tab-stop:144.0pt;
=09mso-level-number-position:left;
=09text-indent:-18.0pt;}
@list l0:level5
=09{mso-level-tab-stop:180.0pt;
=09mso-level-number-position:left;
=09text-indent:-18.0pt;}
@list l0:level6
=09{mso-level-tab-stop:216.0pt;
=09mso-level-number-position:left;
=09text-indent:-18.0pt;}
@list l0:level7
=09{mso-level-tab-stop:252.0pt;
=09mso-level-number-position:left;
=09text-indent:-18.0pt;}
@list l0:level8
=09{mso-level-tab-stop:288.0pt;
=09mso-level-number-position:left;
=09text-indent:-18.0pt;}
@list l0:level9
=09{mso-level-tab-stop:324.0pt;
=09mso-level-number-position:left;
=09text-indent:-18.0pt;}
ol
=09{margin-bottom:0cm;}
ul
=09{margin-bottom:0cm;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext=3D"edit" spidmax=3D"1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext=3D"edit">
<o:idmap v:ext=3D"edit" data=3D"1" />
</o:shapelayout></xml><![endif]-->
</head>
<body lang=3D"EN-AU" link=3D"blue" vlink=3D"purple">
<div class=3D"WordSection1">
<p class=3D"MsoNormal"><span lang=3D"EN-US">Hello<span style=3D"color:#1F4=
97D">,</span></span><o:p></o:p></p>
<p class=3D"MsoNormal"><span lang=3D"EN-US" style=3D"color:#1F497D">&nbsp;=
</span><o:p></o:p></p>
<p class=3D"MsoNormal"><span lang=3D"EN-US" style=3D"color:black">Thank yo=
u again for your interest in our clinical trials. Please see brief outline=
 of a new research project below.</span><span style=3D"color:black"><o:p><=
/o:p></span></p>
<p class=3D"MsoPlainText"><span style=3D"font-size:11.0pt;font-family:&quo=
t;Calibri&quot;,&quot;sans-serif&quot;;color:#F4330C"><o:p>&nbsp;</o:p></s=
pan></p>
<p class=3D"MsoPlainText"><b><span style=3D"font-size:11.0pt;font-family:&=
quot;Calibri&quot;,&quot;sans-serif&quot;;color:#6600CC">We are inviting a=
ll healthy males aged 18-70 years and healthy females of non-child bearing=
 potential aged 18-70 years to participate in a research project
 &nbsp;called NN001 by providing a blood sample. Participants who provide =
a blood sample will receive a reimbursement of $25.
<o:p></o:p></span></b></p>
<p class=3D"MsoPlainText"><b><span style=3D"font-size:11.0pt;font-family:&=
quot;Calibri&quot;,&quot;sans-serif&quot;;color:#6600CC">Please also feel =
free to forward this email to any of your healthy friends aged 18-70 years=
 who satisfy the above criteria and who may also be interested.<o:p></o:p>=
</span></b></p>
<p class=3D"MsoPlainText"><span style=3D"font-size:11.0pt;font-family:&quo=
t;Calibri&quot;,&quot;sans-serif&quot;;color:#3333FF"><o:p>&nbsp;</o:p></s=
pan></p>
<p class=3D"MsoNormal"><b><u>NN001 </u></b>-This research project aims to =
evaluate the metabolism status of about 2000 healthy adult Caucasian volun=
teers. It has been found that certain common gene mutations may affect the=
 way that certain drugs are metabolised
 by the body. By analysing a single sample of a person&#8217;s blood for t=
he presence of these common gene mutations, their metabolism status can be=
 determined. This research will assist us in understanding the metabolism =
status as it applies to the wider adult population.
 Each participant&#8217;s results will be recorded in a secure password pr=
otected database which we may use in the future to recruit participants wi=
th a specific metabolic status for future clinical trials. There is no obl=
igation for volunteers who provide a blood
 sample to participate in any further studies however you will be notified=
 about future studies for which you could potentially be eligible.
<o:p></o:p></p>
<p class=3D"MsoNormal"><o:p>&nbsp;</o:p></p>
<p class=3D"MsoPlainText"><span style=3D"font-size:11.0pt;font-family:&quo=
t;Calibri&quot;,&quot;sans-serif&quot;">Please ensure you also read the hy=
perlinked Participant Information &amp; Consent Form (PICF) which gives mo=
re detail about this research project.</span><span style=3D"font-family:&q=
uot;Calibri&quot;,&quot;sans-serif&quot;">
</span><span style=3D"font-size:11.0pt;font-family:&quot;Calibri&quot;,&qu=
ot;sans-serif&quot;">If, after reading the PICF you are interested in prov=
iding us with a blood sample then please<span style=3D"color:black"> call =
us on
</span></span><b><span style=3D"font-size:12.0pt;font-family:&quot;Calibri=
&quot;,&quot;sans-serif&quot;;color:black">1800 243 733</span></b><span st=
yle=3D"font-size:11.0pt;font-family:&quot;Calibri&quot;,&quot;sans-serif&q=
uot;;color:black"> or respond to this email and include your phone number.=

</span><span style=3D"font-size:11.0pt;font-family:&quot;Calibri&quot;,&qu=
ot;sans-serif&quot;">We will then call you back as soon as possible. Pleas=
e note however, that when we return your call it will be from our
<u>private line</u>. Also, if you get our voicemail, it&#8217;s just becau=
se we are busy answering other calls so please keep trying to get through =
to us.<o:p></o:p></span></p>
<p class=3D"MsoPlainText"><span style=3D"font-size:11.0pt;font-family:&quo=
t;Calibri&quot;,&quot;sans-serif&quot;"><o:p>&nbsp;</o:p></span></p>
<p class=3D"MsoPlainText"><span style=3D"font-size:11.0pt;font-family:&quo=
t;Calibri&quot;,&quot;sans-serif&quot;">Please click
<a href=3D"http://clinicalstudies.com.au/locker/data/public/b0ce691d0493a9=
a3e85d3e2b7e29a29b.php?lang=3Den">
here</a> to view the PICF (Participant Information &amp; Consent Form)<spa=
n style=3D"color:#1F497D"><o:p></o:p></span></span></p>
<p class=3D"MsoNormal"><span style=3D"color:#1F497D"><o:p>&nbsp;</o:p></sp=
an></p>
<p class=3D"MsoNormal"><b>Our Location</b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; C=
entre for Clinical Studies <span lang=3D"EN-US">
(AMREP Precinct Alfred Hospital)<span style=3D"color:#0033CC"> </span></sp=
an><span style=3D"color:blue"><a href=3D"http://clinicalstudies.com.au/wp-=
content/uploads/2014/02/AMREP-CCS-Access-MAP.pdf">AMREP access map</a></sp=
an><span style=3D"color:#1F497D"><o:p></o:p></span></p>
<p class=3D"MsoNormal"><span lang=3D"EN-US">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&=
nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nb=
sp; Level 5, 89 Commercial Road,
<o:p></o:p></span></p>
<p class=3D"MsoNormal"><span lang=3D"EN-US">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&=
nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nb=
sp; Melbourne, 3004</span><span style=3D"color:blue">.</span><o:p></o:p></=
p>
<p class=3D"MsoNormal">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nb=
sp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp; <span style=3D"color:#1F497D">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </sp=
an>
Click <a href=3D"https://maps.google.com.au/maps?q=3D89&#43;commercial&#43=
;road&#43;melbourne&#43;3004&amp;ie=3DUTF-8&amp;hq=3D&amp;hnear=3D0x6ad668=
22902afed9:0xca1cf794638a5956,85-89&#43;Commercial&#43;Rd,&#43;Melbourne&#=
43;VIC&#43;3004&amp;gl=3Dau&amp;ei=3DrwD8UqTNL4GRkwX88YH4Aw&amp;ved=3D0CCY=
Q8gEwAA">
here</a> for the <b><span style=3D"color:#FF2DFF">Google map</span></b>.<o=
:p></o:p></p>
<p class=3D"MsoPlainText"><span style=3D"font-size:11.0pt;font-family:&quo=
t;Calibri&quot;,&quot;sans-serif&quot;;color:#1F497D"><o:p>&nbsp;</o:p></s=
pan></p>
<p class=3D"MsoNormal"><b><span style=3D"color:#6600CC">Please note that i=
f you have previously provided us with a blood sample then you cannot part=
icipate in this sub-study again as we already have your genotype results. =
However, if you know of anyone who may
 be interested, we would very much appreciate it if you pass on the inform=
ation.<o:p></o:p></span></b></p>
<p class=3D"MsoNormal"><b><span style=3D"color:#1F497D"><o:p>&nbsp;</o:p><=
/span></b></p>
<p class=3D"MsoPlainText"><b><span style=3D"font-size:11.0pt;font-family:&=
quot;Calibri&quot;,&quot;sans-serif&quot;">Participants Required:<o:p></o:=
p></span></b></p>
<p class=3D"MsoPlainText" style=3D"margin-left:36.0pt;text-indent:-18.0pt;=
mso-list:l0 level1 lfo2">
<![if !supportLists]><span style=3D"font-size:11.0pt;font-family:Symbol"><=
span style=3D"mso-list:Ignore">&middot;<span style=3D"font:7.0pt &quot;Tim=
es New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D"font-size:11.0pt;font-family=
:&quot;Calibri&quot;,&quot;sans-serif&quot;">Healthy Caucasian Males (aged=
 18-70 years)<o:p></o:p></span></p>
<p class=3D"MsoPlainText" style=3D"margin-left:36.0pt;text-indent:-18.0pt;=
mso-list:l0 level1 lfo2">
<![if !supportLists]><span style=3D"font-size:11.0pt;font-family:Symbol"><=
span style=3D"mso-list:Ignore">&middot;<span style=3D"font:7.0pt &quot;Tim=
es New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D"font-size:11.0pt;font-family=
:&quot;Calibri&quot;,&quot;sans-serif&quot;">Healthy Women who are not of =
child bearing potential eg post menopausal (aged 18-70 years)<o:p></o:p></=
span></p>
<p class=3D"MsoPlainText" style=3D"margin-left:36.0pt;text-indent:-18.0pt;=
mso-list:l0 level1 lfo2">
<![if !supportLists]><span style=3D"font-size:11.0pt;font-family:Symbol"><=
span style=3D"mso-list:Ignore">&middot;<span style=3D"font:7.0pt &quot;Tim=
es New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D"font-size:11.0pt;font-family=
:&quot;Calibri&quot;,&quot;sans-serif&quot;">Weigh<span style=3D"color:#1F=
497D">t
</span><span style=3D"color:black">&#8211; greater</span><span style=3D"co=
lor:#1F497D"> </span>
<span style=3D"color:black">50 kgs</span><o:p></o:p></span></p>
<p class=3D"MsoPlainText" style=3D"margin-left:36.0pt;text-indent:-18.0pt;=
mso-list:l0 level1 lfo2">
<![if !supportLists]><span style=3D"font-size:11.0pt;font-family:Symbol"><=
span style=3D"mso-list:Ignore">&middot;<span style=3D"font:7.0pt &quot;Tim=
es New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D"font-size:11.0pt;font-family=
:&quot;Calibri&quot;,&quot;sans-serif&quot;">BMI: 18-30<o:p></o:p></span><=
/p>
<p class=3D"MsoPlainText" style=3D"margin-left:36.0pt;text-indent:-18.0pt;=
mso-list:l0 level1 lfo2">
<![if !supportLists]><span style=3D"font-size:11.0pt;font-family:Symbol"><=
span style=3D"mso-list:Ignore">&middot;<span style=3D"font:7.0pt &quot;Tim=
es New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D"font-size:11.0pt;font-family=
:&quot;Calibri&quot;,&quot;sans-serif&quot;">No medical conditions<o:p></o=
:p></span></p>
<p class=3D"MsoPlainText" style=3D"margin-left:36.0pt;text-indent:-18.0pt;=
mso-list:l0 level1 lfo2">
<![if !supportLists]><span style=3D"font-size:11.0pt;font-family:Symbol"><=
span style=3D"mso-list:Ignore">&middot;<span style=3D"font:7.0pt &quot;Tim=
es New Roman&quot;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span style=3D"font-size:11.0pt;font-family=
:&quot;Calibri&quot;,&quot;sans-serif&quot;">Do not smoke more than 3 ciga=
rettes per day<o:p></o:p></span></p>
<p class=3D"MsoPlainText"><span style=3D"font-size:11.0pt;font-family:&quo=
t;Calibri&quot;,&quot;sans-serif&quot;;color:#1F497D"><o:p>&nbsp;</o:p></s=
pan></p>
<p class=3D"MsoPlainText"><span style=3D"font-size:11.0pt;font-family:&quo=
t;Calibri&quot;,&quot;sans-serif&quot;">Reimbursement:
<b>$25 cash<o:p></o:p></b></span></p>
<p class=3D"MsoPlainText"><b><span style=3D"font-size:11.0pt;font-family:&=
quot;Calibri&quot;,&quot;sans-serif&quot;"><o:p>&nbsp;</o:p></span></b></p=
>
<p class=3D"MsoNormal">Please also visit our website at<span style=3D"colo=
r:#1F497D">
<a href=3D"http://www.clinicalstudies.com.au">www.clinicalstudies.com.au</=
a> <o:p></o:p></span></p>
<p class=3D"MsoPlainText"><b><span style=3D"font-size:11.0pt;font-family:&=
quot;Calibri&quot;,&quot;sans-serif&quot;"><o:p>&nbsp;</o:p></span></b></p=
>
<p class=3D"MsoNormal">To view our Participant Information Brochure please=
 <a href=3D"http://www.nucleusnetwork.com.au/Upload/Content/File/Email%20r=
elated/Volunteer%20Brochure%20(2).pdf">
click here</a> and read more about our organisation and about clinical tri=
als generally.<span style=3D"color:red"><o:p></o:p></span></p>
<p class=3D"MsoPlainText"><b><span style=3D"font-size:11.0pt;font-family:&=
quot;Calibri&quot;,&quot;sans-serif&quot;"><o:p>&nbsp;</o:p></span></b></p=
>
<p class=3D"MsoNormal"><b><span style=3D"color:#C00000">If you do not wish=
 to receive any further emails from us then please reply to this email wit=
h the word &#8216;unsubscribe&#8217; in the subject box.<o:p></o:p></span>=
</b></p>
<p class=3D"MsoPlainText"><span style=3D"font-size:8.0pt;font-family:&quot=
;Calibri&quot;,&quot;sans-serif&quot;"><o:p>&nbsp;</o:p></span></p>
<p class=3D"MsoNormal"><b><span style=3D"font-size:8.0pt;color:#C00000"><o=
:p>&nbsp;</o:p></span></b></p>
<p class=3D"MsoPlainText"><span style=3D"font-size:11.0pt;font-family:&quo=
t;Calibri&quot;,&quot;sans-serif&quot;">Thank you again for your interest.=
<o:p></o:p></span></p>
<p class=3D"MsoNormal"><span style=3D"color:#1F497D"><o:p>&nbsp;</o:p></sp=
an></p>
<p class=3D"MsoNormal">Kind Regards<o:p></o:p></p>
<p class=3D"MsoNormal"><o:p>&nbsp;</o:p></p>
<p class=3D"MsoNormal"><span style=3D"color:#1F497D"><o:p>&nbsp;</o:p></sp=
an></p>
<p class=3D"MsoNormal"><b><span style=3D"font-size:22.0pt;font-family:&quo=
t;Edwardian Script ITC&quot;;color:#1F497D">Natalie Bakota<o:p></o:p></spa=
n></b></p>
<p class=3D"MsoNormal"><span style=3D"color:#1F497D"><o:p>&nbsp;</o:p></sp=
an></p>
<p class=3D"MsoNormal"><span style=3D"color:#1F497D"><o:p>&nbsp;</o:p></sp=
an></p>
<p class=3D"MsoNormal"><a href=3D"http://www.facebook.com/pages/Centre-for=
-Clinical-Studies/199371513417842"><span style=3D"color:#1F497D;text-decor=
ation:none"><img border=3D"0" width=3D"43" height=3D"43" id=3D"Picture_x00=
20_1" src=3D"cid:image001.jpg@01CF4F5D.83213C60" alt=3D"See full size imag=
e"></span></a><span style=3D"color:#1F497D">&nbsp;<b>You
 can now follow us on Facebook<o:p></o:p></b></span></p>
<p class=3D"MsoNormal"><span style=3D"font-family:&quot;Arial&quot;,&quot;=
sans-serif&quot;;color:#1F497D"><o:p>&nbsp;</o:p></span></p>
<p class=3D"MsoNormal"><span style=3D"color:#1F497D">Natalie Bakota|Recrui=
tment Officer|
</span><b><span style=3D"color:#00B0F0">Centre for Clinical Studies</span>=
</b><span style=3D"color:#99CC00">
</span><span style=3D"color:#1F497D">|&nbsp;<br>
Office: | Level 5 Burnet Institute | AMREP Precinct | 89 Commercial Road |=
&nbsp;Victoria 3004 | Australia<br>
Mail: | PO Box 6083, St Kilda Road Central, Melbourne, 8008, Victoria, Aus=
tralia<br>
Telephone: | t: 1800 243 733 |&nbsp;t: 03 9076 8936 |&nbsp;f: 03 9076 8940=
 <o:p></o:p></span></p>
<p class=3D"MsoNormal"><b><u><span lang=3D"FR" style=3D"color:#00B0F0"><a =
href=3D"mailto:N.Bakota@nucleusnetwork.com.au"><span style=3D"color:#00B0F=
0">N.Bakota@nucleusnetwork.com.au</span></a></span></u></b><b><span lang=3D=
"FR" style=3D"color:#00B0F0">&nbsp;&nbsp;
<a href=3D"http://www.clinicalstudies.com.au/"><span style=3D"color:#00B0F=
0">www.clinicalstudies.com.au</span></a></span><span style=3D"color:#00B0F=
0"><o:p></o:p></span></b></p>
<p class=3D"MsoNormal"><b><i><span style=3D"color:#1F497D">Nucleus Network=
, Australia's Clinical Research Centre, operates in association with Centr=
e for Clinical Studies, Clinical Trials Consulting and its network partner=
s</span></i></b><span style=3D"color:#1F497D"><o:p></o:p></span></p>
<p class=3D"MsoNormal"><span style=3D"color:#1F497D"><o:p>&nbsp;</o:p></sp=
an></p>
<p class=3D"MsoNormal"><span style=3D"color:#1F497D"><o:p>&nbsp;</o:p></sp=
an></p>
<p class=3D"MsoNormal"><span style=3D"color:#1F497D"><o:p>&nbsp;</o:p></sp=
an></p>
<p class=3D"MsoNormal"><o:p>&nbsp;</o:p></p>
</div>
<br clear=3D"both">
______________________________________________________________________<BR>=

This email has been scanned by the Symantec Email Security.cloud service.<=
BR>
For more information please visit http://www.symanteccloud.com<BR>
______________________________________________________________________<BR>=

</body>
</html>

--_000_43607F02F7F979429DE2661B9FCBF6DF3C61DEF3PRNEX2010nucleu_--

--_004_43607F02F7F979429DE2661B9FCBF6DF3C61DEF3PRNEX2010nucleu_
Content-Type: image/jpeg; name="image001.jpg"
Content-Description: image001.jpg
Content-Disposition: inline; filename="image001.jpg"; size=1251;
	creation-date="Thu, 03 Apr 2014 05:55:27 GMT";
	modification-date="Thu, 03 Apr 2014 05:55:27 GMT"
Content-ID: <image001.jpg@01CF4F5D.83213C60>
Content-Transfer-Encoding: base64
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--_004_43607F02F7F979429DE2661B9FCBF6DF3C61DEF3PRNEX2010nucleu_--
